Suboxone High, Help Needed for paper?

Question by wvu9787: Suboxone High, Help Needed for paper?
hi, first off i would like to say i don’t not do drugs, except alcohol and tobacco, i dont not condone drug use. I am doing a paper for class on prescripion drug abuse. my question is does the drug suboxone get a person “high” if used in a abusive way (chewing, snorting) and if so what are is the users high like(experence), and also what are the normal dosage (mg.) that a user would take to achive the high.

once again this is for my school paper, so please dont take it the worng way.

thanks to you all
(also sorry for the spelling errors, never was my best subject lol)

Best answer:

Answer by CEEG
suboxone is a drug made to get off opiates. it does not get you high. it tricks the receptors in your brain to think your getting high therefore you dont get withdrawal symptoms .-makes you feel satisfied with out needing the drug. methadone on the other hand can get you high. do some internet research

Give your answer to this question below!

 

Empowering the patients

Filed under: buprenorphine treatment

And as part of on-going efforts, Jiwa Baru has been advocating MAT as a positive step forward in drug dependency therapy. In MAT, the administration of buprenorphine-naloxone has been a successful pharmacotherapy in treating drug addiction.
Read more on The Sun Daily

 

Genes Found That May Protect Infants of Addicted Mothers

Filed under: buprenorphine treatment

The babies were exposed to addiction treatments methadone or buprenorphine while in the womb. They all had their DNA analyzed. The researchers found that infants with a variation of the OPRM1 gene were in the hospital 8.5 days fewer than those who …
Read more on Bloomberg

 

Titan Pharmaceuticals' Probuphine Program to Be Presented at ASAM Medical

Filed under: buprenorphine treatment

About Probuphine(R) Probuphine is an investigational subdermal implant designed to deliver continuous and persistent, around the clock blood levels of buprenorphine for six months following a single treatment, and to simplify patient compliance and …
Read more on MarketWatch (press release)